glp-1 weight loss wegovy Pill Wins FDA Approval as First Oral Treatment for Obesity and Professor Receives Grant to Study
Description
Recent evidence from the STEP-HFpEF and STEP-HFpEF-DM trials provides the first robust data supporting the efficacy of GLP-1 RAs, specifically semaglutide, in improving the quality of life in obese patients with HFpEF

Keep reading to learn about the similarities and differences between these two medications.
Triagonists (for example GLP-1/GIP/glucagon) are currently in pre-clinical or early clinical development

Transform your health and confidence today.
Meals heat in about 90 seconds in heat-sealed trays and arrive packaged with quality ingredients and practical sustainability in mind

Learn the 2026 eligibility rules for donor centers and why you must disclose if you take Ozempic.